Holen Sie sich die Stockscreener-App
29.00
2.16%
-0.64
Schlusskurs vom Vortag:
$29.64
Offen:
$29.68
24-Stunden-Volumen:
37,016
Relative Volume:
1.96
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.04%
1M Leistung:
+19.83%
6M Leistung:
+95.42%
1J Leistung:
+5.08%
1-Tages-Spanne:
$28.35
$29.68
1-Wochen-Bereich:
$27.62
$29.68
52-Wochen-Spanne:
$13.42
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Firmenname
Virtus Lifesci Biotech Clinical Trials Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BBC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
29.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
321.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
653.02 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
656.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
248.10 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
589.50 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Aktie (BBC) Neueste Nachrichten
What MACD trends signal for Virtus LifeSci Biotech Clinical Trials stockWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Will Virtus LifeSci Biotech Clinical Trials stock return to pre crash levelsMarket Movers & Proven Capital Preservation Methods - newser.com
The Zacks Analyst Blog Highlights BWET, GOEX, SLVP, LIT and BBC - sharewise.com
Best-Performing ETFs of Last Week - sharewise.com
Canadian Equities Shine: ETFs to Capture the Momentum - The Globe and Mail
2 High Risk ETFs That Aren’t Leveraged, Inverse, or Single-Stock - Investing.com
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
How to Take Advantage of moves in (BBC) - news.stocktradersdaily.com
(BBC) Trading Report - news.stocktradersdaily.com
(BBC) Trading Signals - news.stocktradersdaily.com
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
5 Top ETFs of Last Week - Yahoo Finance
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
Pharma Stocks Look Cheap. Here's One Way to Invest. - Nasdaq
Long Term Trading Analysis for (BBC) - news.stocktradersdaily.com
The 5 Best Biotech ETFs of 2024 - ETF.com
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - CMC Markets
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Top and Flop Industry ETFs of Q3 - Nasdaq
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
ALPS’ Biotech ETF SBIO Week's Top Performer - ETF Trends
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Zacks Investment Research
Biotech ETFs Are Making a Comeback - ETF Trends
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Zacks Investment Research
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point - ETF Trends
Betting on Biotech Bear Market Expiration Date - ETF Trends
How to Pick a Biotech ETF - Investment U
Positioning for Biotech Bounceback - ETF Trends
Make Biotech Cash Considerations With SBIO - ETF Trends
Some Biotech Stocks Are Now Cheap - ETF Trends
Biotech M&A Could Finally Perk Up in 2022 - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
ETF Exchange: Latest ETF News & Insights | Pensions & Investments - Pensions & Investments
Biotech Stocks Have Colds, but They Can Heal - ETF Trends
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - ETF.com
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Yahoo Finance
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
More than Just COVID: Hot ETFs for Medical Breakthroughs - ETF Trends
Finanzdaten der Virtus Lifesci Biotech Clinical Trials Etf-Aktie (BBC)
Es liegen keine Finanzdaten für Virtus Lifesci Biotech Clinical Trials Etf (BBC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):